| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.40B | $993.0M | $657.2M |
| YoY Revenue Growth % | +41.0% | +51.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $329.9M | $222.3M | $130.1M |
| Operating Margin % | 23.6% | 22.4% | 19.8% |
| Net Income (GAAP) | $231.8M | $174.7M | $103.8M |
| EBITDA (Normalized) | $339.7M | $228.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $285.0M | $236.5M | $280.1M |
| Capital Expenditures (CapEx) | $12.3M | $7.7M | — |
| Free Cash Flow (FCF) | $272.7M | $228.7M | $280.1M |
| FCF Margin % | 19.5% | 23.0% | 42.6% |
| Return on Invested Capital (ROIC %) | 95.0% | 95.0% | — |
| Cash & Short-Term Equivalents | $472.5M | $495.7M | — |
| Total Debt (Short + Long Term) | $286.0K | $274.0K | — |
| Total Stockholders' Equity | $513.9M | $405.0M | — |